Plasma surgery market 2022
Cutting coagulation systems based on plasma technology and surgical plasma ablation systems have already significantly influenced the way the ablation procedure is performed and are widely adopted in modern surgical practices. A new study by Persistent Market Research (PMR) suggests that the global market for plasma analyses will exceed the revenue in value 56 million dollars Until the end 2019 and there will be a healthy adoption of plasma surgery over the next decade.
Since plasma surgery involves relatively little tissue damage after a traditional electrosurgical procedure, this demand will continue to see an upward trend over the next few years. Improved outcomes leading to quality of life and long-term survival benefits will further contribute to its rapidly increasing appeal.
Get a sample copy of this report @ https://www.persistencemarketresearch.com/samples/28726
Company profiles:
- Surgical plasma
- Mechan Europe Ltd
- Bovie Medical Corporation (Apyx Medical Corporation)
- CONMED Corporation
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/28726
Important points – plasma surgery market research
- Significant benefits of plasma surgery system, increasing awareness of plasma technology, improved reimbursement scenarios for surgical reconstruction, and a wider indication pool for dissection, coagulation, and ablation are key factors influencing the plasma surgery market in developing regions.
- A high upfront cost is a negative influence on end users’ decision to purchase plasma analysis systems. To solve this problem, manufacturers offer plasma analysis systems at a competitive price that lowers the cost of the plasma generator and the cost of testing.
- Plasma ablation systems with high-level precision and a procedural advantage over laser-guided electrosurgery are expected to generate significant revenues.
- Increasing adoption of plasma analysis for dissection in otolaryngology compared to an ablation procedure indicates higher revenue potential.
Fast track approvals for extended labeling for plasma analysis devices are expected to renew interest in plasma analysis technology and disrupt the electrosurgical device business.
Key players prioritize strategic acquisitions for a regional stronghold
Key manufacturers are entering the plasma analysis market by strategically focusing on mergers and acquisitions, considering the disruptive technology of these systems. Manufacturers are focusing on expanding indication and application to increase profitability. With regard to these changes in the market, another prominent factor affecting the plasma analysis market is the entry of upstream and downstream manufacturers. Market leaders constantly strive to strengthen their market leadership.
In 2018, Bovie Medical Corporation agreed to sell its core business to Symmetry Surgical Inc. in a deal with a capital value of about 97 million dollars in cash. With the Bovie Medical portfolio, Symmetric acquired the Renuvion™ system, used in cosmetic technology and cosmetic surgery.
Access the full report @ https://www.persistencemarketresearch.com/checkout/28726
What does the report cover?
Continuous Market Research offers a unique perspective and actionable insights on plasma surgery in its latest study, which presents historical demand assessment from 2014 – 2018 and forecasts from 2019 – 2029 based on product category (neutral plasma surgery system, plasma ablation systems and cold plasma surgical systems), application (ablation, excision and dissection), and end user (specialty clinics, ambulatory surgical centers and hospitals) in seven key regions.
About us: Persistence market research
Contact Us:
Persistence Market Research Address
– 305 Broadway, 7th Floor, New York City, NY 10007 United States
US Ph. – +1-646-568-7751
US-Canada toll free – +1 800-961-0353
Sales – sales@persistencemarketresearch .com